Salar Mousa: Effect of COVID-19 on Initiation of Antithrombotic Therapy Post-Stroke in Sweden
Salar Mousa, PHD Student at Örebro University, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”I am very excited to share our newly published study examining the effect of COVID-19 pandemic on the initiation of antithrombotic therapy after stroke in Sweden.
Published in Basic and Clinical Pharmacology and Toxicology.
I would like to sincerely thank my supervisors and co-authors from Örebro University, Uppsala University and Gothenburg University for their support and work on this project.”
Title: Trends in Antithrombotic Therapy Initiation Among Patients With Stroke Pre- and Post–COVID-19 in Sweden—An Interrupted Time Series Study
Authors: Salar Mousa, Katarina Persson, Maria Palmetun-Ekbäck, Fredrik Nyberg, Huiqi Li, Björn Wettermark, Mohammad Hossein Hajiebrahimi
Read the Full Article on Basic and Clinical Pharmacology and Toxicology
Stay updated on all scientific advances with Hemostasis Today.
-
Feb 13, 2026, 11:21Matías J Alet Joins The Journal of Stroke and Cerebrovascular Diseases as Section Editor
-
Feb 13, 2026, 11:17Wolfgang Miesbach: Sophie Susen’s ”Long‑Term Prophylaxis in VWD” Talk at EAHAD 2026
-
Feb 13, 2026, 11:06Jennifer Beauchamp: Early Stroke Sign and Symptom Recognition Tool Developed by UTHealth Houston
-
Feb 13, 2026, 11:00Christoph B. Olivier: Can We Stay Ahead of Valve Thrombosis?
-
Feb 13, 2026, 10:53Mattia Galli: Waiting for “Better Evidence” May Delay Better Treatment for Patients
-
Feb 13, 2026, 06:01Heghine Khachatryan: Privileged To Participate In the ASH MMENA Partner Societies Leadership Meeting
-
Feb 12, 2026, 16:36Tagreed Alkaltham: Tranexamic Acid in PBM
-
Feb 12, 2026, 16:35Paul Lambis Announces Maria Hadjidemetriou as a Speaker at Cyprus Diaspora Forum
-
Feb 12, 2026, 16:34Rahul Bhargava: Breaking Myths About Bone Marrow Transplant